Elevance Health Inc. (ELV) 当前追踪市盈率 (P/E) 为 12.4, 前瞻市盈率为 12.1. 追踪盈利收益率为 8.03%, 前瞻盈利收益率 8.26%. PEG 3.90. 格雷厄姆数为 $337.65.
本页证实的标准:
SharesGrow 综合评分： 62/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 15.4 | -4.39 | 1.51 | 0.45 | 1.80% |
| 2017 | 15.0 | 0.27 | 2.17 | 0.64 | 1.22% |
| 2018 | 17.8 | -15.40 | 2.34 | 0.73 | 1.16% |
| 2019 | 16.1 | 0.54 | 2.43 | 0.74 | 1.06% |
| 2020 | 17.6 | -5.71 | 2.43 | 0.66 | 1.18% |
| 2021 | 18.5 | 0.48 | 3.13 | 0.82 | 0.98% |
| 2022 | 20.9 | -7.64 | 3.40 | 0.79 | 1.00% |
| 2023 | 18.4 | 5.50 | 2.80 | 0.64 | 1.27% |
| 2024 | 14.4 | 8.48 | 2.08 | 0.49 | 1.76% |
| 2025 | 13.7 | -5.63 | 1.77 | 0.39 | 1.97% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $9.21 | $84.98B | $2.47B | 2.9% |
| 2017 | $14.35 | $90.04B | $3.84B | 4.3% |
| 2018 | $14.19 | $92.11B | $3.75B | 4.1% |
| 2019 | $18.47 | $104.21B | $4.81B | 4.6% |
| 2020 | $17.98 | $121.87B | $4.57B | 3.8% |
| 2021 | $24.73 | $138.64B | $6.1B | 4.4% |
| 2022 | $24.28 | $156.6B | $5.89B | 3.8% |
| 2023 | $25.22 | $171.34B | $5.99B | 3.5% |
| 2024 | $25.68 | $176.81B | $5.98B | 3.4% |
| 2025 | $25.12 | $199.13B | $5.66B | 2.8% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $25.86 | $25.43 – $27.38 | $193.05B | $183.52B – $218.07B | 16 |
| 2027 | $29.03 | $28.17 – $31.25 | $197.1B | $190.26B – $209.88B | 14 |
| 2028 | $34.43 | $32.88 – $37.40 | $208.24B | $208.1B – $208.38B | 4 |
| 2029 | $43.72 | $41.81 – $48.10 | $219.95B | $212.53B – $236.87B | 2 |
| 2030 | $46.13 | $44.11 – $50.74 | $229.5B | $221.77B – $247.16B | 2 |
